Cardiovascular disease

Cardiovascular disease (CVD) can be a general term for heart or blood vessel conditions.
It is sometimes associated with an accumulation of fatty deposits in the arteries (atherosclerosis) and an exaggerated risk of blood clots.
It may even be associated with artery injury in organs such as the brain, heart, kidneys, and eyes.
Cardiovascular disease is one of the most common causes of death and disability in the UK of Great Britain and Northern Ireland, but it will usually be prevented by leading a healthy lifestyle.

Subtopics:

Endocrine Functions and Metabolic Interactions | Endothelial dysfunction and clinical syndromes | Aging and Cognitive Function | Lipoproteins | Kidney and Hypertension | Atherosclerosis and colonary artery disease | Life style choices, Risk Factors | Diet and Homocysteinemia | Contribution of pollutants and Environmental Chemicals | Genetic Susceptibility | Precautions coronary interventions and Cardiac Surgery | Omega 3 fatty acid in prevention

Market Statistics:

The cardiovascular disease market, which includes hypertension, dyslipidemia, and thrombotic events, is expected to expand from $129.2 billion in 2015 to $146.4 billion by 2022.

The global cardiovascular devices market is expected to grow at a 6.9% CAGR from USD 54.08 billion in 2021 to USD 86.27 billion in 2028.

The global cardiovascular medicines market is predicted to increase at a CAGR of 5.3% from $87.79 billion in 2020 to $92.41 billion in 2021. The increase is primarily due to companies reorganising their operations and recovering from the impact of COVID-19. At a CAGR of 4%, the market is estimated to reach $107.77 billion in 2025.